Differences between pulmonologists, thoracic surgeons and radiation oncologists in deciding on the treatment of stage i non-small cell lung cancer: A binary choice experiment

Radiotherapy and Oncology

Volumn 115, Issue 3, 2015, Pages 361-366

  Hopmans, Wendy ^a   Zwaan, Laura ^a,c   Senan, Suresh ^a   Van Der Wulp, Ineke ^a   Damman, Olga C ^a   Hartemink, Koen J ^b   Smit, Egbert F ^a,b   Timmermans, Danielle R M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Non small cell lung cancer; Practice variation; Stereotactic ablative radiotherapy; Surgery; Thoracic oncologists

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER THERAPY; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE PULMONARY DISEASE GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE SCORE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; HEALTH SURVEY; HUMAN; MEDICAL DECISION MAKING; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT PREFERENCE; PRIORITY JOURNAL; PULMONOLOGIST; RADIATION ONCOLOGIST; RESPIRATORY TRACT DISEASE ASSESSMENT; STEREOTACTIC BODY RADIATION THERAPY; THORAX SURGERY; TREATMENT INDICATION; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION PERFORMANCE STATUS; CARCINOMA, NON-SMALL-CELL LUNG; CHRONIC OBSTRUCTIVE LUNG DISEASE; LUNG NEOPLASMS; LUNG RESECTION; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84946416594     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.05.006     Document Type: Article

References (22)

1. Vansteenkiste J., De Ruysscher D., Eberhardt W.E.E., et al. Early and locally non-small cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24(suppl 6):vi89-98.
2. Louie AV, Palma DA, Dahele M, Rodriques GB, Senan S. Management of early stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons. Radioth Oncol published online: December 10, 2014.
3. M. Lüchtenborg, E. Jakobsen, M. Krasnik, K.M. Linklater, A. Mellemgaard, and H. Møller The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients Eur J Cancer 48 2012 3386 3395
4. J.E. Rosen, J.G. Hancock, W.A. Kim, F.C. Detterbeck, and D.J. Boffa Predictors of mortality after surgical manangement of lung cancer in the national cancer database Ann Thorac Surg 98 2014 1953 1960
5. S.O. Rogers, S.W. Gray, M.B. Landrum, and et al. Variations in surgeon treatment recommendations for lobectomy in early-stage non-small cell lung cancer by patient age and comorbidity Ann Surg Oncol 17 2010 1581 1588
6. D. Moghanaki, and T. Karas Surgery versus SABR for NSCLC Lancet Oncol 14 2013 e490 e491
7. B. Zhang, F. Zhu, X. Ma, and et al. Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis Radioth Oncol 112 2014 250 255
8. M. Brada, A. Pope, and M. Baumann SABR in NSCLC - the beginning of the end or the end of the beginning? Radioth Oncol 2015 135 137
9. J.E. Wennberg Unwarranted variations in healthcare delivery: implications for academic medical centres BMC 325 2002 961 964
10. P. Lantz, N. Janz, A. Fagerlin, and et al. Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer Health Serv Res 40 2005 745 767
11. J.A. Howington, M.G. Blum, A.C. Chang, A.A. Balekian, and S.C. Murthy Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 2013 278S 313S
12. Lim E., Baldwin D., Beckles M., et al. Guidelines on the radical management of patients with lung cancer. Thorax 2010;65(suppl3):iii1-27.
13. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2005.
14. M. Dewar, and R.W. Curry Jr. Chronic obstructive pulmonary disease: diagnostic considerations Am Fam Physician 73 2006 669 676
15. D.J. Pierson Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources Respir Care 51 2006 277 288
16. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chronic Dis 40 1987 373 383
17. M.M. Oken, R.H. Creech, D.C. Tormey, and et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 1982 649 655
18. A.M. Stiggelbout, T. van der Weijden, M.P.T. de Wit, and et al. Shared decision making: really putting patients at the centre of healthcare BMJ 344 2012 e256
19. G. Elwyn, D. Frosch, R. Thomson, and et al. Shared decision making: a model for clinical practice J Gen Intern Med 27 2012 1361 1367
20. L.G. Glance, T.M. Osler, and M.D. Neuman Redesigning surgical decision making for high-risk patients N Engl J Med 371 2014 1379 1381
21. J.J. Louviere, and H.J.P. Timmermans Testing the external validity of hierarchical conjoint analysis models of recreational destination choice Leisure Sci 14 1992 179 194
22. E.M. Caruso, D.A. Rahnev, and M.R. Banaji Using conjoint analysis to detect discrimination: revealing covert preferences from overt choices Soc Cogn 27 2009 128 137